Tonix Pharmaceuticals Holding Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14.2M, a 49.2% increase year-over-year.
  • Tonix Pharmaceuticals Holding Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$135M, a 11.8% decline year-over-year.
  • Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$117M, a 5.84% decline from 2022.
  • Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$110M, a 19.4% decline from 2021.
  • Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$92.3M, a 82.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$135M -$14.2M +$13.8M +49.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$149M -$78.8M -$50.4M -178% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$98.6M -$14.9M +$18.1M +54.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$117M -$27.3M +$4.36M +13.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$121M -$28M +$1.01M +3.47% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$122M -$28.4M -$5.22M -22.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$117M -$33M -$6.59M -24.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$110M -$31.7M -$2.13M -7.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$108M -$29M -$10.5M -56.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$97.6M -$23.1M +$413K +1.75% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$98.1M -$26.4M -$5.76M -27.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$92.3M -$29.6M -$12.5M -73.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 -$79.8M -$18.5M -$6.54M -54.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$73.2M -$23.6M -$9.37M -66.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$63.8M -$20.7M -$13.4M -184% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$50.5M -$17M -$8.31M -95.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$42.1M -$12M -$4.15M -53% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$38M -$14.2M -$8.34M -143% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$29.7M -$7.27M -$1.04M -16.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$28.6M -$8.71M -$1.12M -14.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$27.5M -$7.84M -$2.36M -43.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$25.1M -$5.84M +$247K +4.06% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$25.4M -$6.23M +$702K +10.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$26.1M -$7.59M -$2.1M -38.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$24M -$5.48M +$307K +5.31% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$24.3M -$6.09M -$1.31M -27.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 -$23M -$6.94M -$1.87M -36.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 -$21.1M -$5.49M +$1.99M +26.6% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-18
Q3 2017 -$23.1M -$5.79M +$1.79M +23.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$24.9M -$4.78M +$5.03M +51.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$29.9M -$5.06M +$8.91M +63.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$38.8M -$7.48M +$5.88M +44% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$44.7M -$7.58M +$5.67M +42.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$50.4M -$9.81M +$1.96M +16.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$52.3M -$14M -$4.3M -44.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$48.1M -$13.4M -$4.37M -48.6% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-03
Q3 2015 -$43.7M -$13.3M -$5.83M -78.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$37.9M -$11.8M -$5.72M -94.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$32.1M -$9.68M -$4.52M -87.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$27.6M -$8.99M -$5.28M -142% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-03
Q3 2014 -$22.3M -$7.42M -$4.33M -140% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-03
Q2 2014 -$18M -$6.04M -$3.96M -190% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-03
Q1 2014 -$14M -$5.16M -$3.16M -158% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-03
Q4 2013 -$10.9M -$3.71M +$264K +6.65% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-03
Q3 2013 -$11.1M -$3.09M -$1.36M -78.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$9.79M -$2.09M -$354K -20.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$9.44M -$2M +$14K +0.69% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$9.45M -$3.97M -$2.38M -150% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$7.07M -$1.73M -$718K -70.7% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$6.35M -$1.73M -$1.38M -387% Apr 1, 2012 Jun 30, 2012 10-Q 2013-11-13
Q1 2012 -$4.97M -$2.01M -$1.5M -292% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 -$3.47M -$1.59M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-28
Q3 2011 -$1.01M -$1.01M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$356K -$353K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$514K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$3.69K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-07
Q2 2010 -$2.4K* Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.